These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25995319)

  • 1. Great Expectations: MicroRNA-30d and Cardiac Resynchronization Therapy.
    Dorn GW
    Circulation; 2015 Jun; 131(25):2172-5. PubMed ID: 25995319
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study".
    Melman YF; Shah R; Danielson K; Xiao J; Simonson B; Barth A; Chakir K; Lewis GD; Lavender Z; Truong QA; Kleber A; Das R; Rosenzweig A; Wang Y; Kass D; Singh JP; Das S
    Circulation; 2016 Feb; 133(6):e389-e390. PubMed ID: 26858296
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter by Sardu et al Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study".
    Sardu C; Paolisso G; Marfella R
    Circulation; 2016 Feb; 133(6):e388. PubMed ID: 26858295
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study.
    Melman YF; Shah R; Danielson K; Xiao J; Simonson B; Barth A; Chakir K; Lewis GD; Lavender Z; Truong QA; Kleber A; Das R; Rosenzweig A; Wang Y; Kass D; Singh JP; Das S
    Circulation; 2015 Jun; 131(25):2202-2216. PubMed ID: 25995320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders.
    Marfella R; Di Filippo C; Potenza N; Sardu C; Rizzo MR; Siniscalchi M; Musacchio E; Barbieri M; Mauro C; Mosca N; Solimene F; Mottola MT; Russo A; Rossi F; Paolisso G; D'Amico M
    Eur J Heart Fail; 2013 Nov; 15(11):1277-88. PubMed ID: 23736534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of miRNA in cardiac resynchronization therapy.
    Sardu C; Marfella R; Santulli G; Paolisso G
    Pharmacogenomics; 2014 Jun; 15(8):1159-68. PubMed ID: 25084208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure.
    Wang J; Gong X; Chen H; Qin S; Zhou N; Su Y; Ge J
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):438-445. PubMed ID: 28127817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoptosis and autophagy in cardiomyocytes].
    Takemura G
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():143-8. PubMed ID: 17511072
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction.
    Zhang R; Niu H; Ban T; Xu L; Li Y; Wang N; Sun L; Ai J; Yang B
    Int J Cardiol; 2013 Jun; 166(1):259-60. PubMed ID: 23079087
    [No Abstract]   [Full Text] [Related]  

  • 10. Advanced research on the microRNA mechanism in heart failure.
    Deng J; Zhong Q
    Int J Cardiol; 2016 Oct; 220():61-4. PubMed ID: 27372044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in heart failure: is the picture becoming less miRky?
    Melman YF; Shah R; Das S
    Circ Heart Fail; 2014 Jan; 7(1):203-14. PubMed ID: 24449811
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes and prognostic impact of apoptotic and inflammatory cytokines in patients treated with cardiac resynchronization therapy.
    Osmancik P; Herman D; Stros P; Linkova H; Vondrak K; Paskova E
    Cardiology; 2013; 124(3):190-8. PubMed ID: 23486075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiac resynchronization in a patient with congenitally corrected transposition of the great arteries].
    Sousa PA; Cavaco D; Adragão P; Teixeira A; Ribeiras R; Martins M; Mendes M
    Rev Port Cardiol; 2014 Jun; 33(6):387.e1-6. PubMed ID: 24999264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Electrophysiologic and Hemodynamic Effects of Cardiac Resynchronization Therapy: From Bench to Bedside and Vice Versa.
    Schreurs R; Wiegerinck RF; Prinzen FW
    Card Electrophysiol Clin; 2015 Dec; 7(4):599-608. PubMed ID: 26596805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Simulation to Personalize Cardiac Resynchronization Therapy.
    Delgado V; Bax JJ
    Circ Cardiovasc Imaging; 2015 Sep; 8(9):e003985. PubMed ID: 26338879
    [No Abstract]   [Full Text] [Related]  

  • 16. The Impact of Diabetes and Comorbidities on the Outcome of Heart Failure Patients Treated With Cardiac Resynchronization Therapy: Implications for Patient Management.
    Boriani G
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27489244
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of cardiac resynchronization therapy on selected inflammatory markers and aldosterone levels in patients with chronic heart failure.
    Przybyła A; Czarnecka D; Kusiak A; Wiliński J; Sondej T; Jastrzebski M; Kawecka-Jaszcz K
    Przegl Lek; 2011; 68(7):359-61. PubMed ID: 22010472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.
    Lang NN; Badar AA; Pettit SJ; Templeton S; Connelly DT; Gardner RS
    Biomark Med; 2014; 8(6):797-806. PubMed ID: 25224936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer Modeling: The Future of Cardiac Resynchronization Therapy Patient Selection?
    Cobb DB; Gold MR
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e006104. PubMed ID: 29326131
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of change in serum bilirubin in predicting left ventricular reverse remodeling and outcomes in heart failure patients with cardiac resynchronization therapy.
    Hosoda J; Ishikawa T; Matsumoto K; Iguchi K; Matsushita H; Ogino Y; Taguchi Y; Sugano T; Ishigami T; Kimura K; Tamura K
    J Cardiol; 2017 Nov; 70(5):416-419. PubMed ID: 28522137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.